Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital
description
Transcript of Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital
![Page 1: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/1.jpg)
Collaboration between inpatient anticoagulation service and hospital reference
laboratory to reduce misdiagnosis of Heparin Induced Thrombocytopenia
Harmony Bowles, PharmDPGY1 Pharmacy Resident
University of New Mexico Hospital
IRB Approval Received
Category C1
Abstract # 49
![Page 2: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/2.jpg)
Disclosure Statement• Harmony Bowles• Investigators have no conflict of interest to
disclose• This study was not funded• Proprietary information or results may be subject
to different interpretations• Speaker’s presentation of this slide indicates
agreement to abide by the non-commercialism guidelines provided in the CE Requirements page
![Page 3: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/3.jpg)
Learning Objectives• Objective #1:
– Describe the role of a multidisciplinary collaboration in reducing overdiagnosis of HIT
• Objective #2:– List financial and clinical benefits of having a
multidisciplinary team involved in diagnosis and management of HIT
Target Audience: Pharmacists
![Page 4: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/4.jpg)
• Level 1 trauma center
• 646 bed tertiary care teaching hospital
• ~50 full-time pharmacists
• Pharmacy-driven inpatient anticoagulation service seven days a week
![Page 5: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/5.jpg)
Pre-Test Assessment Questions• T/F: The use of a validated pre-test probability tool known as
the 4T’s score has been shown to improve the process of identifying patients at low risk for HIT.
• T/F: Collaboration between inpatient anticoagulation service and the reference laboratory will lead to a reduction in the number of inappropriate HIT antibody ELISA tests performed.
• T/F: Multidisciplinary collaboration leads to cost savings by decreasing the number of patients being inappropriately tested and treated for HIT.
![Page 6: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/6.jpg)
Background• Heparin Induced Thrombocytopenia (HIT) is a pro-
thrombotic, immune- mediated adverse reaction to heparin or low-molecular weight heparin (LMWH) therapy1
• Accurate diagnosis requires:– Patient clinical presentation – Laboratory results
• Most institutions utilize an enzyme-immunoassay (ELISA) to detect HIT antibodies (Ab)– High sensitivity: >90% negative predictive value – Low specificity: high potential for false positives2
1. Arepally G, Ortel T. N Engl J Med 2006;355:809-17.2. Lo G, Sigouin C, Warkentin T. Am J Heamatol. 2007;82:1043-1043.
![Page 7: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/7.jpg)
Background• Hospitalized patients have multiple reasons for developing
thrombocytopenia
• Inappropriately ordered non-specific ELISA Ab increases potential for overdiagnosis of HIT
• The 4T’s score3 –Validated assessment tool to identify patients at risk for HIT–Based on 4 patient parameters:
• Magnitude of platelet drop• Timing of thrombocytopenia in relation to heparin exposure• Presence of new thrombosis• Other possible reasons for thrombocytopenia
–High negative predictive value
3. Lo G, Juhl D, Warkentin T, et al. J Thromb Heamost 2006; 4:759-765.
![Page 8: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/8.jpg)
Study Objectives• Primary objective:
– Evaluate impact of multidisciplinary collaboration in reducing number of inappropriate Ab tests performed, thereby reducing the misdiagnosis of HIT
• Secondary objective:– Evaluate potential cost savings of decreasing Ab testing
and use of direct thrombin inhibitors (DTIs) for inappropriate treatment of HIT
![Page 9: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/9.jpg)
Methods – Study Design
• Study design: Single center, pre-post prospective study with retrospective chart review
• Inclusion criteria: All patients for whom Ab was ordered during study period – ≥ 18 years of age– Sufficient data available to calculate 4T’s score
![Page 10: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/10.jpg)
Methods – Intervention Outline
![Page 11: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/11.jpg)
Methods – Data Collection• At risk population
– Patients exposed to unfractionated heparin (UFH) or low molecular weight heparin (LMWH) products
– Patients for whom an Ab tests ordered during pre- and post-intervention period obtained from reference laboratory
• Patients with Ab ordered – Manual chart review for patient demographics, characteristics,
pre-defined bleeding and thrombotic events
• 4T’s score independently and retrospectively calculated by 3 evaluators to establish inter-rater reliability (IRR)
![Page 12: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/12.jpg)
Methods – Data Collection• Cost:
– Hospital cost for performing Ab test obtained from reference laboratory
– Drug treatment cost per patient for those receiving direct thrombin inhibitor (DTI) in pre-intervention period evaluated by:
• DTI acquisition cost• Number of patients treated • Number of doses dispensed
![Page 13: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/13.jpg)
Methods – Data Analysis
• Fleiss kappa performed to assess IRR between 3 evaluators
• Chi-square used to analyze categorical variables
• Student t-test used to analyze continuous variables
• All data entered and analyzed with SPSS software version 19.0
![Page 14: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/14.jpg)
Results – IRR
• IRR– Fleiss kappa = (0.643)– Interpretation: Good IRR4
4. Fleiss J. Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley and Sons; 1987.
![Page 15: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/15.jpg)
Results – Study Population
*NS: No statistical difference
At Risk Population (# of patients)
Pre- Intervention
Post- Intervention p-value
Admitted to UNMH 19,312 19,422 -Exposed to UFH/LMWH 6,867 7,809 NS
Patients with Ab ordered(% of total exposed patients)
176(2.5%)
108(1.4%)
<0.001
![Page 16: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/16.jpg)
Results – Demographics
Patients with Ab ordered
CharacteristicPre-Intervention
(n=176)Post-Intervention
(n=108) p-valueAge, mean (SD), years 56.9
(14.5)56.4 (16.2)
NS
Male 87 (49.4%) 55 (50.9%) NS
*NS: No statistical difference
![Page 17: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/17.jpg)
Results – Ab Testing
![Page 18: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/18.jpg)
Results – Ab Testing
n=127 n=127n=74
n=33
![Page 19: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/19.jpg)
Results – Cost
Cost incurred
Hospital cost per Ab test $35.00Hospital drug cost per patient treated for HIT(Pre-intervention)
$6400.00
Patients with Ab orderedPre-Intervention
(n=176)Post-Intervention
(n=108) p-valuePatients treated for HIT 16
(9.1%)9
(8.3%)0.912
# of Ab tests cancelled 0 46 <0.001
![Page 20: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/20.jpg)
Results – Cost Savings
Estimated annual cost savings=($15.92 – $7.66) x 7809= $64,502.34
![Page 21: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/21.jpg)
Results – Adverse EventsPatients with Ab ordered
Adverse outcomePre-
(n=176)Post-
(n=108) p-valueBleeding event 10.2% 6.5% 0.279
Thrombotic event 0.6% 0% 0.433
• No bleeding events directly associated with HIT treatment during hospitalization
• Single thrombotic event in the pre-intervention period in patient with negative HIT Ab result
![Page 22: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/22.jpg)
Study Limitations• Calculation of 4T’s score performed retrospectively
• Data collected from chart review dependent on accurate documentation
• Patients could have received treatment for bleeding or thrombosis events at another facility
• Total cost evaluation did not include pharmacist time to perform intervention
• Limited external validity as not all hospitals have dedicated inpatient anticoagulation service
![Page 23: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/23.jpg)
Conclusions• Impact of multidisciplinary collaboration
– Reduction in inappropriate HIT testing – Reduction in misdiagnosis of HIT without causing
adverse clinical outcomes
• Use of the 4T’s score by a pharmacists is a means to improving accuracy of HIT testing and diagnosis and improving patient outcomes
• Substantial cost savings may be realized through decreased lab testing, decreased DTI use and avoidance of unnecessarily treating patients for HIT
![Page 24: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/24.jpg)
Post-Test Assessment Questions
• T/F: The use of a validated pre-test probability tool known as the 4T’s score has been shown to improve the process of identifying patients at low risk for HIT
• T/F: Collaboration between inpatient anticoagulation service and the reference laboratory will lead to a reduction in the number of inappropriate HIT ELISA tests performed
• T/F: Multidisciplinary collaboration leads to cost savings by decreasing the number of patients being inappropriately treated for HIT
![Page 25: Harmony Bowles, PharmD PGY1 Pharmacy Resident University of New Mexico Hospital](https://reader030.fdocuments.net/reader030/viewer/2022033102/5681675c550346895ddc280d/html5/thumbnails/25.jpg)
Acknowledgements
• Allison Burnett, PharmD • Richard D’Angio, PharmD, BCPS• Matthew Borrego, Ph.D., M.S• Tiffany Montoya, PharmD